Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancers
Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden..
Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden..
Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.;Malaghan Inst Med Res, Newtown, New Zealand..
Aquesta Uropathol, Brisbane, Qld, Australia..ORCID iD: 0000-0001-5796-1791
Show others and affiliations
2025 (English)In: Journal of Clinical Pathology, ISSN 0021-9746, E-ISSN 1472-4146, Vol. 78, no 6, p. 429-431Article in journal (Refereed) Published
Abstract [en]

Reporting of prostate cancer grade has drifted to higher reported grades over the past decades. In prostate cancers diagnosed on needle biopsy of 1 72 112 men reported to The National Prostate Cancer Register of Sweden 2000-2020, we also noted a grade shift among high-grade cancers. We applied multinomial logistic regression to assess time trends. Among International Society of Urological Pathology (ISUP) grade 4 cancers, Gleason score 3+5 increased from 8% in 2000 to 22% in 2020, while Gleason score 4+4 decreased from 88% to 77%. Among ISUP grade 5, Gleason score 4+5 and 5+4 cancers increased from 85% to 93%, while Gleason score 5+5 decreased from 15% to 7%. This may be explained by a reluctance to assign Gleason scores composed of a uniform grade following recommendations to include minimal components of higher grade in the scores. These changes are obscured by merging Gleason scores into ISUP grades.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2025. Vol. 78, no 6, p. 429-431
Keywords [en]
PROSTATE, Classification, CARCINOMA, EPIDEMIOLOGY
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-566829DOI: 10.1136/jcp-2025-210062ISI: 001444438600001PubMedID: 40081884OAI: oai:DiVA.org:uu-566829DiVA, id: diva2:1996394
Funder
Swedish Cancer Society, CAN 20 1358 PjFsSwedish Cancer Society, 22 22051PjThe Cancer Society in Stockholm, 204043Available from: 2025-09-09 Created: 2025-09-09 Last updated: 2025-09-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Stattin, Pär

Search in DiVA

By author/editor
Samaratunga, HemamaliStattin, Pär
By organisation
Urology
In the same journal
Journal of Clinical Pathology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 25 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf